Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom

C. Green, J. Dinnes, A.L. Takeda, B.H. Cuthbertson

    Research output: Contribution to journalArticlepeer-review

    20 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom'. Together they form a unique fingerprint.

    Medicine & Life Sciences

    Social Sciences